21 May 2013
Keywords: s-p, tra, drug, meets, ph, ii, endpoints
Article | 02 April 2007
US drug major Schering-Plough reported positive results from a Phase II trial of its novel oral thrombin receptor antagonist (TRA) ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
2 April 2007
20 May 2013
© 2013 thepharmaletter.com